Design of a Novel HIV-1 Fusion Inhibitor That Displays a Minimal Interface for Binding Affinity

Reported herein are the design, biological activities, and biophysical properties of a novel HIV-1 membrane fusion inhibitor. α-Helix-inducible X-EE-XX-KK motifs were applied to design an enfuvirtide analogue 2 that exhibited highly potent anti-HIV activity against wild-type HIV-1, enfuvirtide-resis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry Vol. 51; no. 3; pp. 388 - 391
Main Authors: Oishi, Shinya, Ito, Saori, Nishikawa, Hiroki, Watanabe, Kentaro, Tanaka, Michinori, Ohno, Hiroaki, Izumi, Kazuki, Sakagami, Yasuko, Kodama, Eiichi, Matsuoka, Masao, Fujii, Nobutaka
Format: Journal Article
Language:English
Published: Washington, DC American Chemical Society 14-02-2008
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Reported herein are the design, biological activities, and biophysical properties of a novel HIV-1 membrane fusion inhibitor. α-Helix-inducible X-EE-XX-KK motifs were applied to design an enfuvirtide analogue 2 that exhibited highly potent anti-HIV activity against wild-type HIV-1, enfuvirtide-resistant HIV-1 strains, and an HIV-2 strain in vitro. Indispensable residues for bioactivity of enfuvirtide, including the residues interacting with the N-terminal heptad repeat and the C-terminal hydrophobic residues, were identified.
Bibliography:istex:85A1913EF870ACF60960E525D1F848024DB37008
Experimental details for peptide preparation, CD spectra measurements, and bioassays and MS and HPLC data. This material is available free of charge via the Internet at http://pubs.acs.org.
ark:/67375/TPS-B2CSMLZ3-2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm701109d